This case study describes a patient with basal cell carcinoma who was given four lines of treatment that were unsuccessful. A personalized approach was subsequently taken, and a beta version of the CureMatch Decision Support System platform was used to guide in the selection of immunotherapy, leading to near complete remission.
This webpage is strictly reserved for healthcare professionals. Please confirm that you are a healthcare professional.
Otherwise, you will be redirected to the institutional part of this website.
Thank you for your understanding.